4.6 Article

Posterior reversible encephalopathy syndrome and autoimmunity

Related references

Note: Only part of the references are listed.
Article Rheumatology

Anti-neutrophil cytoplasmic antibody-associated vasculitis complicated by thrombotic microangiopathy with posterior reversible encephalopathy syndrome successfully treated with eculizumab: A case report

Fumiya Kitamura et al.

Summary: This case report presents a patient with anti-neutrophil cytoplasmic antibody-associated vasculitis-related thrombotic microangiopathy who showed significant improvement after treatment with eculizumab. It suggests that complement activation may be involved in the pathogenesis of this disease, and prompt use of eculizumab may be an effective strategy for preventing organ damage.

MODERN RHEUMATOLOGY CASE REPORTS (2022)

Article Clinical Neurology

Acute posterior reversible encephalopathy syndrome (PRES) in setting of interferon-beta use: case presentation with reduction of edema in 72 h after cessation of interferon-beta therapy with sub-clinical inflammation

Nicholas Dietz et al.

Summary: This case describes a middle-aged female with multiple sclerosis who developed typical symptoms of posterior reversible encephalopathy syndrome (PRES) after long-term interferon-beta therapy, showing significant improvement in symptoms after discontinuation, with noticeable improvements in imaging and inflammatory markers.

BMC NEUROLOGY (2021)

Review Immunology

Posterior reversible encephalopathy syndrome: A neuropsychiatric manifestation of systemic lupus erythematosus

Martin Valdez-Lopez et al.

Summary: Posterior Reversible Encephalopathy Syndrome (PRES) is an acute neurological syndrome characterized by seizures, altered mental status, headache, and visual disturbances. It is often associated with Systemic Lupus Erythematosus (SLE), with SLE causing alterations in pathways implicated in the development of PRES. This suggests that PRES in the setting of SLE may be considered a distinct neuropsychiatric syndrome.

AUTOIMMUNITY REVIEWS (2021)

Review Clinical Neurology

Posterior Reversible Encephalopathy Syndrome

Alexandra N. Gewirtz et al.

Summary: This review provides updated information on the clinical presentation, diagnosis, and treatment of posterior reversible encephalopathy syndrome (PRES), and highlights COVID-19 as a potential risk factor for PRES. The syndrome is theorized to be related to disordered autoregulation and endothelial dysfunction, with treatment focusing on addressing underlying causes and removing offending agents.

CURRENT PAIN AND HEADACHE REPORTS (2021)

Article Immunology

The Innate Immune Response Characterizes Posterior Reversible Encephalopathy Syndrome

Christopher Nelke et al.

Summary: The study found that total protein levels in the cerebrospinal fluid (CSF) of posterior reversible encephalopathy syndrome (PRES) patients are elevated, indicating an innate immune response rather than adaptive immunity in the pathophysiology of PRES. Analysis of monocyte subsets showed an increase in CD14(++)/CD16(+) monocytes in the peripheral blood (PB) and CSF of PRES patients, serving as a marker for disease severity.

JOURNAL OF CLINICAL IMMUNOLOGY (2021)

Review Immunology

Association of Circulating Vascular Endothelial Growth Factor Levels With Autoimmune Diseases: A Systematic Review and Meta-Analysis

Haoting Zhan et al.

Summary: Circulating VEGF levels are associated with autoimmune diseases and may predict disease manifestations and activity in patients, indicating potential therapeutic implications.

FRONTIERS IN IMMUNOLOGY (2021)

Article Rheumatology

Anti-glomerular basement membrane antibody disease complicated by posterior reversible encephalopathy syndrome

Yumeko Taniguchi et al.

Summary: Anti-GBM antibody disease and PRES coexisting is a rare case of two rare diseases, possibly caused by immunological abnormalities and subsequent inflammatory reactions leading to endothelial dysfunction.

MODERN RHEUMATOLOGY CASE REPORTS (2021)

Editorial Material Clinical Neurology

Posterior Reversible Encephalopathy Syndrome, Multiple Sclerosis and interferon therapy: Association, co-incidence or convoluted interplay?

Vasileios C. Mastorodemos et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)

Review Clinical Neurology

Posterior reversible encephalopathy syndrome

Thomas G. Liman et al.

CURRENT OPINION IN NEUROLOGY (2019)

Article Primary Health Care

Hyperglycemia-induced posterior reversible encephalopathy syndrome: A rare cause of reversible blindness

Nishanth Dev et al.

JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE (2019)

Review Clinical Neurology

Controversy of posterior reversible encephalopathy syndrome: what have we learnt in the last 20 years?

Bo Gao et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)

Review Clinical Neurology

PRES: Review of Histological Features

Nicholas Willard et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2018)

Review Clinical Neurology

Severe neurologic complications of immune checkpoint inhibitors: a single-center review

Sarah Mancone et al.

JOURNAL OF NEUROLOGY (2018)

Article Clinical Neurology

Clinical outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a multicentric case-control study

Javier Merayo-Chalico et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)

Review Clinical Neurology

Neurologic complications of immune checkpoint inhibitors

Andreas F. Hottinger

CURRENT OPINION IN NEUROLOGY (2016)

Review Immunology

Autoimmunity, neuroinflammation, pathogen load: A decisive crosstalk in neuropsychiatric SLE

Helene Jeltsch-David et al.

JOURNAL OF AUTOIMMUNITY (2016)

Article Rheumatology

The spectrum of posterior reversible encephalopathy in systemic lupus erythematosus

Amritha Budhoo et al.

CLINICAL RHEUMATOLOGY (2015)

Article Biochemistry & Molecular Biology

Anti-IL-6 neutralizing antibody modulates blood-brain barrier function in the ovine fetus

Jiyong Zhang et al.

FASEB JOURNAL (2015)

Review Biochemistry & Molecular Biology

Pathogenesis of Brain Edema and Investigation into Anti-Edema Drugs

Shotaro Michinaga et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)

Article Medicine, General & Internal

Albuminocytologic Dissociation in Posterior Reversible Encephalopathy Syndrome

Sudhir Datar et al.

MAYO CLINIC PROCEEDINGS (2015)

Article Neurosciences

Blood-Brain Barrier Breakdown in Reduced Uterine Perfusion Pressure: A Possible Model of Posterior Reversible Encephalopathy Syndrome

Luiz Carlos Porcello Marrone et al.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2014)

Article Clinical Neurology

Blood transfusion-related posterior reversible encephalopathy syndrome

Zhen-Yu Zhao et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)

Article Rheumatology

Pathogenesis of neuropsychiatric systemic lupus erythematosus and potential biomarkers

Petros Efthimiou et al.

Modern Rheumatology (2014)

Review Urology & Nephrology

Pre-eclampsia part 1: current understanding of its pathophysiology

Tinnakorn Chaiworapongsa et al.

NATURE REVIEWS NEPHROLOGY (2014)

Article Medicine, Research & Experimental

Posterior reversible encephalopathy syndrome: The endothelial hypotheses

A. Marra et al.

MEDICAL HYPOTHESES (2014)

Article Medicine, Research & Experimental

Posterior reversible encephalopathy syndrome in the setting of COPD: Proposed pathogenesis

Christopher Dardis et al.

MEDICAL HYPOTHESES (2013)

Review Neurosciences

The Role of Magnesium in the Management of Cerebral Vasospasm

Mitchell J. Odom et al.

NEUROLOGY RESEARCH INTERNATIONAL (2013)

Article Medicine, Research & Experimental

Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease

Azeb Tadesse Argaw et al.

JOURNAL OF CLINICAL INVESTIGATION (2012)

Article Immunology

Increased Prevalence of IL-17-Producing Peripheral Blood Lymphocytes in Pre-eclampsia

Gergely Toldi et al.

AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2011)

Article Radiology, Nuclear Medicine & Medical Imaging

Posterior Reversible Encephalopathy Syndrome (PRES) With Immune System Activation, VEGF Up-Regulation, and Cerebral Amyloid Angiopathy

Julia Kofler et al.

JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2011)

Article Rheumatology

Posterior Reversible Encephalopathy Syndrome in Systemic Lupus Erythematosus

Irlapati Rajendra Varaprasad et al.

JOURNAL OF RHEUMATOLOGY (2011)

Review Rheumatology

Posterior Reversible Encephalopathy Syndrome: An Emerging Disease Manifestation in Systemic Lupus Erythematosus

Claire E. Barber et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2011)

Article Medicine, General & Internal

Posterior Reversible Encephalopathy Syndrome: Associated Clinical and Radio logic Findings

Jennifer E. Fugate et al.

MAYO CLINIC PROCEEDINGS (2010)

Article Biochemistry & Molecular Biology

IL-1 or TNF receptor gene deletion delays onset of encephalopathy and attenuates brain edema in experimental acute liver failure

Chantal Bemeur et al.

NEUROCHEMISTRY INTERNATIONAL (2010)

Article Endocrinology & Metabolism

Interleukin-6 activates arginine vasopressin neurons in the supraoptic nucleus during immune challenge in rats

Karine Palin et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)

Article Clinical Neurology

Posterior reversible encephalopathy syndrome as a complication of acute lupus activity

Jose Fidel Baizabal-Carvallo et al.

CLINICAL NEUROLOGY AND NEUROSURGERY (2009)

Article Rheumatology

Antiphospholipid Syndrome and Reversible Posterior Leukoencephalophaty Syndrome

Monica Bandettini di Poggio et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2009)